Vertex Pharmaceuticals Incorporated (BIT:1VRTX)

Italy flag Italy · Delayed Price · Currency is EUR
393.30
0.00 (0.00%)
At close: Jun 5, 2025, 5:30 PM CET
-9.05%
Market Cap 100.34B
Revenue (ttm) 10.27B
Net Income (ttm) -914.93M
Shares Out n/a
EPS (ttm) -3.55
PE Ratio n/a
Forward PE 23.38
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 9
Open 393.30
Previous Close 393.30
Day's Range 393.30 - 393.30
52-Week Range 369.50 - 486.10
Beta n/a
RSI 47.60
Earnings Date Aug 4, 2025

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The com... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Employees 6,100
Stock Exchange Borsa Italiana
Ticker Symbol 1VRTX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.